# pleural mesothelioma stages

Current Management and Future Perspective in Pleural Mesothelioma » Platin-based chemotherapy with pemetrexed has been the backbone of meaningful treatment in pleural mesothelioma for the last 16 years, alongside vinorelbine and gemcitabine, which show only modest response. Recently, a nivolumab and ipilimumab combination… Ncbi.nlm.nih.gov

Malignant Mesothelioma » Malignant mesothelioma is a rare growth of mesothelial cells strongly associated with asbestos exposure. Mesothelial cells form the lining layers of the viscera. Mesothelioma can occur at any mesothelial layer such as the peritoneum or pericardium. The pleural layer is by far the most commonly affected, giving rise to malignant pleural mesothelioma. [1][2][3][4]The subtypes of asbestos strongly associated with malignant mesothelioma are the amosite and crocidolite asbestos. Ncbi.nlm.nih.gov

Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin Levels | NEJM » We investigated the presence of osteopontin in pleural mesothelioma and determined serum osteopontin levels in three populations: subjects without cancer who were exposed to asbestos, subjects with… Nejm.org

Life Expectancy in Pleural and Peritoneal Mesothelioma » Background. Mesothelioma is a rare cancer with a historically dire prognosis. We sought to calculate life expectancies for patients with pleural or peritoneal mesothelioma, both at time of diagnosis and several years later, and to examine whether survival… Ncbi.nlm.nih.gov

Life Expectancy in Pleural and Peritoneal Mesothelioma » <i>Background</i>. Mesothelioma is a rare cancer with a historically dire prognosis. We sought to calculate life expectancies for patients with pleural or peritoneal mesothelioma, both at time of diagnosis and several years later, and to examine whether survival has improved in recent years.<i> Methods</i>. Data on 10,258 pleural and 1,229 peritoneal patients from the SEER US national cancer database, 1973–2011, were analyzed using the Cox proportional hazards regression model.<i> Results</i>. The major factors related to survival were age, sex, stage, grade, histology, and treatment. Survival improved only modestly over the study period: 0.5% per year for pleural and 2% for peritoneal.<i> Conclusions</i>. Life expectancies were markedly reduced from normal, even amongst 5-year survivors with the most favorable characteristics and treatment options. Hindawi.com